What, Why & How

This episode features an interview with Maggie Phelps from the Iowa Board of Pharmacy discussing updates and tips for using Iowa's Prescription Monitoring Program (PMP) to improve pharmacy practice and compliance.

This episode discusses the Board of Pharmacy's proposed emergency adoption to amend regulations allowing pharmacy technicians to administer vaccines beyond COVID and pediatric immunizations, addressing upcoming flu and pneumonia seasons.

This episode provides updates on recent pharmacy board legislation implementation, protocol changes, and board member appointments affecting pharmacy practice.

This episode is a legislative briefing by the Iowa Pharmacy Association covering their 2025 priorities and talking points for pharmacists meeting with lawmakers.

This episode discusses the Iowa Pharmacy Association's 2023 legislative priorities, focusing on modernizing the outdated Pharmacy Practice Act to allow pharmacists to provide full patient care without legal barriers.

This episode recaps 2024 federal advocacy efforts in pharmacy and healthcare law, featuring experts from ASHP and the Iowa Pharmacy Association discussing legislative and regulatory impacts.

This episode discusses the Iowa Board of Pharmacy's end-of-year meeting, focusing on electronic prescribing waivers and pharmacists' roles during the COVID-19 pandemic.

This episode discusses the Iowa Insurance Division's release of PBM rules, covering the legislative process and grassroots efforts behind the related bill passed in 2022.

This episode discusses the implementation of standard of care frameworks in pharmacy practice, featuring insights from pharmacists in Idaho and Alaska, following Iowa's recent adoption.

This episode discusses Iowa's upcoming transition to the Uniform Multistate Pharmacy Jurisprudence Exam (UMPJE) for pharmacist licensure starting April 2026, featuring experts from the National Association of Boards of Pharmacy.

This episode features an interview with Dr.

This episode features an interview with Andrew Funk, Executive Director of the Iowa Board of Pharmacy, discussing the board's regulatory role beyond disciplinary actions, including public protection and upcoming topics like USP compounding standards.

This episode features an interview with Anne Schlephorst, the new Executive Director of the Iowa Board of Pharmacy, discussing her background, role, and recent regulatory changes affecting pharmacy practice.

This episode recaps the 2024 Iowa legislative session with pharmacist and state representative John Forbes, discussing pharmacy law updates, Medicaid funding, and PBM reform.

This episode explains the rulemaking process for pharmacy regulations in Iowa, featuring experts discussing how rules are adopted and implemented.

This episode discusses recent legislation and rulemaking affecting pharmacy practice, including bills on controlled substances and pharmacy interns, as explained by IPA's Director of Public Affairs and a Board of Pharmacy member.

This episode discusses updated security and controlled substance accountability rules adopted by the Iowa Board of Pharmacy, including requirements for alarm and video surveillance systems in pharmacies.

This episode features an interview with Andrea Seip from the Iowa Insurance Division to discuss recent updates on the regulation and oversight of pharmacy benefit managers (PBMs) in Iowa, focusing on legislative changes and their impact on pharmacy practice.

This episode discusses the FDA Memorandum of Understanding regarding interstate dispensing of compounded drugs, the Board of Pharmacy's rulemaking, and compliance requirements for pharmacies.

This episode features an interview with Angela Horst, Executive Director of the Iowa Board of Pharmacy, discussing the board's roles in rulemaking, licensing, and regulatory updates impacting pharmacy practice.

This episode discusses Iowa's PBM reform bill, Senate File 383, with IPA's contract lobbyist Kate Walton, exploring its legislative journey and impact on pharmacy practice.

This episode discusses the Board of Pharmacy's virtual meeting during COVID-19, focusing on the impact of the pandemic on rulemaking processes and pharmacy practice.

This episode features an interview with Andrew Funk from NABP discussing the UPJE and future developments in pharmacy license portability and regulatory changes.

This episode provides a legislative briefing on the 2024 Iowa legislative session, focusing on pharmacy advocacy and what to expect during Pharmacy Day on the Hill.

This episode discusses federal regulatory changes to DIR fees affecting pharmacies, survey findings on potential closures, and policy responses with expert Michael Baxter.

This episode discusses the Board of Pharmacy's proposed rules for collaborative practice agreements and test & treat protocols following recent legislation.

This episode introduces the new government affairs team at the Iowa Pharmacy Association and welcomes Sue Mears from the Iowa Board of Pharmacy to discuss pharmacy-related regulatory and legislative updates.

This episode discusses recent actions by the Board of Pharmacy including board member reappointments, new PMP resources, and upcoming rule changes affecting pharmacy practice.

This episode features Scott Pace discussing recent legislative and regulatory changes impacting pharmacy practice, particularly focusing on PBM regulation and healthcare law.

This episode discusses the impact of Iowa's State Government Realignment Bill (Senate File 514) on the Board of Pharmacy, including its move from the Department of Health and Human Services and the intent to streamline government operations.

This episode discusses the Board of Pharmacy's recent meeting, including the designation of lobbyists and proposed legislation to allow nurses to perform pharmacy-related activities under pharmacist supervision.

This episode features an interview with Brett Barker, a pharmacist recently elected to the Iowa House of Representatives, discussing his background and the intersection of pharmacy and government.

This episode discusses Executive Order 10 from Governor Reynolds, which requires state agencies like the Board of Pharmacy to review and potentially re-promulgate their administrative rules within a set timeframe.

This episode explains the Iowa Pharmacy Disposal Kit Dispensing Program, which enables pharmacists to provide convenient at-home drug disposal kits to patients for safe medication disposal.

This episode discusses the Board of Pharmacy's actions, including granting authority to speak on legislation and registering for IPA's 2020 bill, with insights from board member Sue Mears.

This episode discusses the Board of Pharmacy's recent meeting, including rule changes for technicians and support persons, and provides an update on legislative bills that have passed the House and are progressing in the Senate.

This episode discusses the Iowa Board of Pharmacy's handling of exemption requests for the upcoming electronic prescribing mandate, including the types of exemptions and their impact on pharmacists.

This episode discusses the IPA Board of Pharmacy's recent meeting actions, focusing on legislative proposals for 2021 and COVID-19 vaccine distribution, with insights from public affairs and board representatives.

This episode discusses the IPA Board of Pharmacy's adoption of rules implementing e-prescribing mandates, including exemptions and how it affects pharmacists' practice.

This episode discusses recent actions by the Board of Pharmacy, including the adoption of technician product verification rules and the appointment of new board members.

This episode provides an update on key regulatory developments from an Iowa Board of Pharmacy meeting, focusing on statewide protocol rules, USP 800 compliance, and e-prescribing of controlled substances.

This episode discusses the Iowa Board of Pharmacy's January 2019 meeting, focusing on regulatory changes to Chapter 4 that clarify supervision rules for pharmacist interns and their impact on pharmacy practice.

This episode discusses regulatory challenges around compounding and med spas, featuring insights from pharmacy board officials on recent meetings and compliance strategies.

This episode discusses the FDA's Memorandum of Understanding on compounding regulations and its implications for pharmacy practice, as explained by IPA's Vice President of Public Affairs and a Board of Pharmacy representative.

This episode explains the rulemaking process of the Board of Pharmacy, including how proposed rules are considered and the role of the Rules Committee.

This episode discusses recent legislative bills from the Iowa Board of Pharmacy, including updates on controlled substances regulations, nursing practice in pharmacies, and telepharmacy requirements.

This episode discusses updates from the Iowa Board of Pharmacy, focusing on a new licensing bill that affects pharmacy practice and includes fee waivers for low-income individuals.

This episode discusses the Iowa Board of Pharmacy's efforts to fill a new seat for a certified pharmacy technician, highlighting challenges in finding qualified applicants and the statutory requirement for gender balance.

This episode features Sue Mears from the Iowa Board of Pharmacy discussing the board's preemptive actions to schedule Epidiolex following FDA approval, including the DEA's rescheduling process and the use of a Notice of Intent Action to expedite availability in Iowa.

This episode features a discussion between host Casey Fisek and guest Sue Mears from the Iowa Board of Pharmacy, focusing on recent meeting outcomes and legislative priorities.